Stephanie DeMarco in The Scientist:
As a person’s own cells that have gone rogue, cancers are as unique as the people they come from. This diversity makes a one-size-fits-all approach to cancer treatment next to impossible. Instead, patients need therapies that can go head-to-head with the exact cancer they’re facing. For years, precision medicine focused on developing therapies directed toward a cancer’s unique genetics, but the development of new cancer treatment strategies has widened its scope immensely.
“Precision medicine is no longer about matching a drug with a target. It’s about selecting the right therapeutic platform for the biology in front of us,” said Katy Rezvani, a cancer cell therapy researcher at the University of Texas MD Anderson Cancer Center and chair of the plenary session “Innovative Treatment Modalities: Shaping the Future of Oncology” at the American Association for Cancer Research (AACR) 2026 annual meeting.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.